Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

334 Press Releases
DateTitleCompany
28 Feb 17 Sanofi Genzyme Recognizes Rare Disease Day 2017 with Programs of Events around the World Sanofi Genzyme,
Published by
Business Wire
27 Feb 17 Sanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses Sanofi ,
Published by
PharmiWeb.com
27 Feb 17 Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility Sanofi,
Published by
GlobeNewswire
14 Feb 17 Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease Sanofi Genzyme,
Published by
Business Wire
09 Feb 17 Sanofi: Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process Sanofi,
Published by
GlobeNewswire
08 Feb 17 Sanofi CEO Interview - FY 2016 Results (video) Sanofi,
Published by
PR Newswire
01 Feb 17 Sanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States Sanofi,
Published by
GlobeNewswire
31 Jan 17 Sanofi Pasteur Announces the Availability of Quadracel™ DTaP-IPV Vaccine for Children 4 Through 6 Years of Age in the U.S. Sanofi Pasteur ,
Published by
PharmiWeb.com
30 Jan 17 Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs Sanofi,
Published by
GlobeNewswire
23 Jan 17 Sanofi : Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
17 Jan 17 Sanofi: SuliquaTM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
06 Jan 17 Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection Sanofi,
Published by
GlobeNewswire
04 Jan 17 Sanofi Announces Soliqua(TM) 100/33 Now Available in the U.S. Sanofi ,
Published by
PharmiWeb.com
04 Jan 17 Sanofi Announces Soliqua(TM) 100/33 Now Available in the U.S. Sanofi,
Published by
GlobeNewswire
03 Jan 17 Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017 Sanofi ,
Published by
PharmiWeb.com
02 Jan 17 Sanofi : Reporting EN Sanofi,
Published by
GlobeNewswire
02 Jan 17 Sanofi Pasteur and MSD end joint vaccines business in Europe Sanofi,
Published by
GlobeNewswire
02 Jan 17 Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017 Sanofi,
Published by
GlobeNewswire
22 Nov 16 Sanofi Receives FDA Approval of Soliqua(TM) 100/33, for the Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
07 Nov 16 Sanofi : Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
04 Nov 16 Sanofi Genzyme Begins Pivotal Phase 3 Trial of NeoGAA Investigational Second-Generation Therapy for Pompe Disease Sanofi Genzyme,
Published by
Business Wire
22 Nov 16 Sanofi Receives FDA Approval of Soliqua™ 100/33 for the Treatment of Adults with Type 2 Diabetes Sanofi ,
Published by
PharmiWeb.com
17 Nov 16 Sanofi and Regeneron Announce Praluent® (alirocumab) Cardiovascular Outcomes Trial will Continue as Planned Following Interim Analysis Sanofi,
Published by
GlobeNewswire
28 Nov 16 Sanofi: Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
12 Dec 16 Sanofi :Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
05 Dec 16 Sanofi Genzyme Announces Start of Phase III Study of Isatuximab for Relapsed and Refractory Multiple Myeloma Sanofi Genzyme,
Published by
Business Wire
11 Nov 16 Sanofi Receives CHMP Recommendation for Approval of SuliquaTM in the EU Sanofi,
Published by
GlobeNewswire
16 Nov 16 Sanofi: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16... Sanofi,
Published by
GlobeNewswire
08 Dec 16 Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA Sanofi,
Published by
GlobeNewswire
20 Dec 16 Sanofi Genzyme Announces Recipients of 2016 Patient Advocacy Leadership (PAL) Awards Sanofi Genzyme,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.